Yeah, we have something to say and we can't wait t
Post# of 30065
Posted On: 09/05/2014 2:19:35 PM
Yeah, we have something to say and we can't wait to get our message out. LOL
On a company note, Aimee reported the audio of the business update call should be on the company website shortly, but this was 2 days ago so I'm not sure how she defines shortly. It's probably out of her control.
If the call quality is better than what was streamed on the phone, I will build and post links to the chapterized audio files as I've done with previous conference calls, so everyone can go directly to specific topics or questions. Seems a waste of time to do the work with the current crappy audio file if a higher quality version will be available. I intend to build the file either way, but am holding out a bit for what will hopefully be a better audio source.
I find it very useful to go back weeks or months later and listen to specific topics. This has been especially beneficial when helping newer investors to understand the process by which Amarantus obtained rights to the LymPro asset, as was discussed in the April 2013 conference call. As Jason Napadano described it in the call... "You guys picked up LymPro for a song... pretty darn cheap."
On a company note, Aimee reported the audio of the business update call should be on the company website shortly, but this was 2 days ago so I'm not sure how she defines shortly. It's probably out of her control.
If the call quality is better than what was streamed on the phone, I will build and post links to the chapterized audio files as I've done with previous conference calls, so everyone can go directly to specific topics or questions. Seems a waste of time to do the work with the current crappy audio file if a higher quality version will be available. I intend to build the file either way, but am holding out a bit for what will hopefully be a better audio source.
I find it very useful to go back weeks or months later and listen to specific topics. This has been especially beneficial when helping newer investors to understand the process by which Amarantus obtained rights to the LymPro asset, as was discussed in the April 2013 conference call. As Jason Napadano described it in the call... "You guys picked up LymPro for a song... pretty darn cheap."
(0)
(0)